位置:首页 > 蛋白库 > SYNJ_CAEEL
SYNJ_CAEEL
ID   SYNJ_CAEEL              Reviewed;        1119 AA.
AC   G5ECL2; B3CJ53; G5EDR8; G5EEJ9;
DT   02-NOV-2016, integrated into UniProtKB/Swiss-Prot.
DT   14-DEC-2011, sequence version 1.
DT   03-AUG-2022, entry version 84.
DE   RecName: Full=Synaptojanin {ECO:0000303|PubMed:10931870};
DE            EC=3.1.3.36 {ECO:0000250|UniProtKB:Q9D2G5};
DE   AltName: Full=Synaptic inositol 1,4,5-trisphosphate 5-phosphatase {ECO:0000250|UniProtKB:Q9D2G5};
DE   AltName: Full=Uncoordinated protein 26 {ECO:0000312|WormBase:JC8.10b};
GN   Name=unc-26 {ECO:0000312|WormBase:JC8.10b};
GN   ORFNames=JC8.10 {ECO:0000312|WormBase:JC8.10b};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239 {ECO:0000312|EMBL:AAG18574.1};
RN   [1] {ECO:0000312|EMBL:AAG18574.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A; B AND C), FUNCTION, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=10931870; DOI=10.1083/jcb.150.3.589;
RA   Harris T.W., Hartwieg E., Horvitz H.R., Jorgensen E.M.;
RT   "Mutations in synaptojanin disrupt synaptic vesicle recycling.";
RL   J. Cell Biol. 150:589-600(2000).
RN   [2] {ECO:0000312|Proteomes:UP000001940}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2 {ECO:0000312|Proteomes:UP000001940};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [3] {ECO:0000305}
RP   SUBCELLULAR LOCATION, AND DISRUPTION PHENOTYPE.
RX   PubMed=14622579; DOI=10.1016/s0896-6273(03)00667-6;
RA   Schuske K.R., Richmond J.E., Matthies D.S., Davis W.S., Runz S., Rube D.A.,
RA   van der Bliek A.M., Jorgensen E.M.;
RT   "Endophilin is required for synaptic vesicle endocytosis by localizing
RT   synaptojanin.";
RL   Neuron 40:749-762(2003).
RN   [4] {ECO:0000305}
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18094048; DOI=10.1091/mbc.e07-07-0719;
RA   Marza E., Long T., Saiardi A., Sumakovic M., Eimer S., Hall D.H.,
RA   Lesa G.M.;
RT   "Polyunsaturated fatty acids influence synaptojanin localization to
RT   regulate synaptic vesicle recycling.";
RL   Mol. Biol. Cell 19:833-842(2008).
RN   [5] {ECO:0000305}
RP   SUBCELLULAR LOCATION, DOMAIN, AND DISRUPTION PHENOTYPE.
RX   PubMed=21029864; DOI=10.1016/j.cell.2010.09.024;
RA   Bai J., Hu Z., Dittman J.S., Pym E.C., Kaplan J.M.;
RT   "Endophilin functions as a membrane-bending molecule and is delivered to
RT   endocytic zones by exocytosis.";
RL   Cell 143:430-441(2010).
RN   [6] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, DOMAIN, AND MUTAGENESIS OF CYS-378; ASP-380
RP   AND ASP-722.
RX   PubMed=25918845; DOI=10.7554/elife.05660;
RA   Dong Y., Gou Y., Li Y., Liu Y., Bai J.;
RT   "Synaptojanin cooperates in vivo with endophilin through an unexpected
RT   mechanism.";
RL   Elife 4:E05660-E05660(2015).
CC   -!- FUNCTION: Probable inositol 5-phosphatase which regulates synaptic
CC       vesicle recycling in neurons by regulating clathrin-mediated
CC       endocytosis. {ECO:0000269|PubMed:10931870, ECO:0000269|PubMed:18094048,
CC       ECO:0000269|PubMed:25918845}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-
CC         bisphosphate) + H2O = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
CC         inositol 4-phosphate) + phosphate; Xref=Rhea:RHEA:22764,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:58178,
CC         ChEBI:CHEBI:58456; EC=3.1.3.36;
CC         Evidence={ECO:0000250|UniProtKB:Q9D2G5};
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle, synaptic
CC       vesicle {ECO:0000269|PubMed:14622579, ECO:0000269|PubMed:21029864}.
CC       Synapse {ECO:0000269|PubMed:14622579, ECO:0000269|PubMed:18094048,
CC       ECO:0000269|PubMed:21029864, ECO:0000269|PubMed:25918845}.
CC       Note=Localizes to puncta at neuromuscular junctions in the nerve cord.
CC       {ECO:0000269|PubMed:14622579, ECO:0000269|PubMed:18094048}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=b {ECO:0000312|WormBase:JC8.10b};
CC         IsoId=G5ECL2-1; Sequence=Displayed;
CC       Name=a {ECO:0000312|WormBase:JC8.10a};
CC         IsoId=G5ECL2-2; Sequence=VSP_058630;
CC       Name=c {ECO:0000312|WormBase:JC8.10c};
CC         IsoId=G5ECL2-3; Sequence=VSP_058629, VSP_058631;
CC       Name=d {ECO:0000312|WormBase:JC8.10d};
CC         IsoId=G5ECL2-4; Sequence=VSP_058632, VSP_058633;
CC   -!- DOMAIN: The Pro-rich domain is dispensable for endocytosis during the
CC       synaptic vesicle recycling, locomotion and for endogenous and evoked
CC       excitatory postsynaptic currents (EPSC) at neuromuscular junctions
CC       (PubMed:21029864, PubMed:25918845). May play a role together with the
CC       SAC domain in targeting unc-26 to synapses (PubMed:25918845).
CC       {ECO:0000269|PubMed:21029864, ECO:0000269|PubMed:25918845}.
CC   -!- DOMAIN: The SAC domain, but not is catalytic activity, is required for
CC       targeting unc-26 to synapses, for locomotion and for normal endogenous
CC       and evoked excitatory postsynaptic currents (EPSC) at neuromuscular
CC       junctions. {ECO:0000269|PubMed:25918845}.
CC   -!- DISRUPTION PHENOTYPE: Viable but small with slow grow and uncoordinated
CC       movements (PubMed:10931870, PubMed:21029864). Synaptic vesicles at
CC       neuromuscular synapses are reduced, arranged linearly and are
CC       dissociated from the synaptic active zone (PubMed:10931870). Several
CC       defects in vesicle recycling including accumulation of endocytic pits
CC       at the neuromuscular junctions and accumulation of coated vesicles
CC       predominantly at synapses of neurons but also near the Golgi in cell
CC       bodies of neurons, muscles, hypodermis and gonadal sheath cells
CC       (PubMed:10931870). Accumulation of endosome-like compartments in
CC       cholinergic and GABA neurons and diffused snb-1/synaptobrevin
CC       distribution along the ventral nerve cord (PubMed:10931870).
CC       Neurotransmission defects characterized by reduced endogenous frequency
CC       of synaptic vesicle fusion, a reduced evoked current amplitude after
CC       one stimulation and a faster decline in evoked response caused by
CC       multiple responses (PubMed:14622579). Resistant to paralysis induced by
CC       Aldicar, an acetylcholinesterase inhibitor which causes acetylcholine
CC       accumulation (PubMed:14622579). {ECO:0000269|PubMed:10931870,
CC       ECO:0000269|PubMed:14622579, ECO:0000269|PubMed:21029864}.
CC   -!- SIMILARITY: Belongs to the synaptojanin family. {ECO:0000305}.
CC   -!- SIMILARITY: In the central section; belongs to the inositol 1,4,5-
CC       trisphosphate 5-phosphatase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF283322; AAG18574.1; -; mRNA.
DR   EMBL; AF283323; AAG18575.1; -; mRNA.
DR   EMBL; AF283324; AAG18576.1; -; mRNA.
DR   EMBL; BX284604; CAB05234.2; -; Genomic_DNA.
DR   EMBL; BX284604; CAC70096.1; -; Genomic_DNA.
DR   EMBL; BX284604; CAQ58127.1; -; Genomic_DNA.
DR   EMBL; BX284604; CAN86614.1; -; Genomic_DNA.
DR   PIR; C88883; C88883.
DR   RefSeq; NP_001023265.1; NM_001028094.2. [G5ECL2-2]
DR   RefSeq; NP_001023266.1; NM_001028095.3. [G5ECL2-1]
DR   RefSeq; NP_001122785.1; NM_001129313.2. [G5ECL2-3]
DR   RefSeq; NP_001129862.1; NM_001136390.2. [G5ECL2-4]
DR   AlphaFoldDB; G5ECL2; -.
DR   SMR; G5ECL2; -.
DR   IntAct; G5ECL2; 11.
DR   STRING; 6239.JC8.10b; -.
DR   EPD; G5ECL2; -.
DR   PaxDb; G5ECL2; -.
DR   PeptideAtlas; G5ECL2; -.
DR   EnsemblMetazoa; JC8.10a.1; JC8.10a.1; WBGene00006763. [G5ECL2-2]
DR   EnsemblMetazoa; JC8.10b.1; JC8.10b.1; WBGene00006763. [G5ECL2-1]
DR   EnsemblMetazoa; JC8.10c.1; JC8.10c.1; WBGene00006763. [G5ECL2-3]
DR   EnsemblMetazoa; JC8.10d.1; JC8.10d.1; WBGene00006763. [G5ECL2-4]
DR   GeneID; 178284; -.
DR   KEGG; cel:CELE_JC8.10; -.
DR   CTD; 178284; -.
DR   WormBase; JC8.10a; CE28239; WBGene00006763; unc-26. [G5ECL2-2]
DR   WormBase; JC8.10b; CE29050; WBGene00006763; unc-26. [G5ECL2-1]
DR   WormBase; JC8.10c; CE40972; WBGene00006763; unc-26. [G5ECL2-3]
DR   WormBase; JC8.10d; CE42707; WBGene00006763; unc-26. [G5ECL2-4]
DR   eggNOG; KOG0566; Eukaryota.
DR   GeneTree; ENSGT00940000170400; -.
DR   InParanoid; G5ECL2; -.
DR   OMA; EYVRPRM; -.
DR   OrthoDB; 359616at2759; -.
DR   PhylomeDB; G5ECL2; -.
DR   Reactome; R-CEL-1660499; Synthesis of PIPs at the plasma membrane.
DR   Reactome; R-CEL-1855183; Synthesis of IP2, IP, and Ins in the cytosol.
DR   Reactome; R-CEL-1855204; Synthesis of IP3 and IP4 in the cytosol.
DR   Reactome; R-CEL-8856828; Clathrin-mediated endocytosis.
DR   SignaLink; G5ECL2; -.
DR   PRO; PR:G5ECL2; -.
DR   Proteomes; UP000001940; Chromosome IV.
DR   Bgee; WBGene00006763; Expressed in germ line (C elegans) and 4 other tissues.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-KW.
DR   GO; GO:0045202; C:synapse; IDA:WormBase.
DR   GO; GO:0008021; C:synaptic vesicle; ISS:WormBase.
DR   GO; GO:0043813; F:phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; ISS:WormBase.
DR   GO; GO:0004439; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; IBA:GO_Central.
DR   GO; GO:0015870; P:acetylcholine transport; IMP:WormBase.
DR   GO; GO:0007010; P:cytoskeleton organization; IMP:WormBase.
DR   GO; GO:0007032; P:endosome organization; IMP:WormBase.
DR   GO; GO:0015812; P:gamma-aminobutyric acid transport; IMP:WormBase.
DR   GO; GO:0048212; P:Golgi vesicle uncoating; IMP:WormBase.
DR   GO; GO:0046855; P:inositol phosphate dephosphorylation; IBA:GO_Central.
DR   GO; GO:0040011; P:locomotion; IMP:WormBase.
DR   GO; GO:0006936; P:muscle contraction; IMP:WormBase.
DR   GO; GO:0046856; P:phosphatidylinositol dephosphorylation; IBA:GO_Central.
DR   GO; GO:0040018; P:positive regulation of multicellular organism growth; IMP:WormBase.
DR   GO; GO:0045933; P:positive regulation of muscle contraction; IMP:WormBase.
DR   GO; GO:0010940; P:positive regulation of necrotic cell death; IGI:WormBase.
DR   GO; GO:0001956; P:positive regulation of neurotransmitter secretion; IMP:WormBase.
DR   GO; GO:0035418; P:protein localization to synapse; IGI:WormBase.
DR   GO; GO:0043058; P:regulation of backward locomotion; IMP:WormBase.
DR   GO; GO:0043059; P:regulation of forward locomotion; IMP:WormBase.
DR   GO; GO:0016185; P:synaptic vesicle budding from presynaptic endocytic zone membrane; IMP:WormBase.
DR   GO; GO:0048488; P:synaptic vesicle endocytosis; IMP:WormBase.
DR   GO; GO:0048489; P:synaptic vesicle transport; IMP:WormBase.
DR   GO; GO:0016191; P:synaptic vesicle uncoating; IMP:WormBase.
DR   GO; GO:0016050; P:vesicle organization; IMP:WormBase.
DR   Gene3D; 3.30.70.330; -; 1.
DR   Gene3D; 3.60.10.10; -; 1.
DR   InterPro; IPR036691; Endo/exonu/phosph_ase_sf.
DR   InterPro; IPR005135; Endo/exonuclease/phosphatase.
DR   InterPro; IPR000300; IPPc.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR002013; SAC_dom.
DR   InterPro; IPR015047; SYNJ1/2_RRM.
DR   Pfam; PF08952; DUF1866; 1.
DR   Pfam; PF03372; Exo_endo_phos; 1.
DR   Pfam; PF02383; Syja_N; 1.
DR   SMART; SM01165; DUF1866; 1.
DR   SMART; SM00128; IPPc; 1.
DR   SUPFAM; SSF56219; SSF56219; 1.
DR   PROSITE; PS50275; SAC; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasmic vesicle; Endocytosis; Hydrolase;
KW   Reference proteome; Synapse.
FT   CHAIN           1..1119
FT                   /note="Synaptojanin"
FT                   /evidence="ECO:0000305"
FT                   /id="PRO_0000438241"
FT   DOMAIN          119..438
FT                   /note="SAC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00183"
FT   REGION          532..826
FT                   /note="Catalytic"
FT                   /evidence="ECO:0000255"
FT   REGION          986..1005
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1042..1119
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1048..1069
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1070..1119
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         500..502
FT                   /note="ESY -> GLF (in isoform c)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_058629"
FT   VAR_SEQ         501..506
FT                   /note="Missing (in isoform a)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_058630"
FT   VAR_SEQ         503..1119
FT                   /note="Missing (in isoform c)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_058631"
FT   VAR_SEQ         506..508
FT                   /note="EYA -> GKL (in isoform d)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_058632"
FT   VAR_SEQ         509..1119
FT                   /note="Missing (in isoform d)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_058633"
FT   MUTAGEN         378
FT                   /note="C->S: Normal synapse localization, locomotion and,
FT                   endogenous and evoked excitatory postsynaptic currents;
FT                   when associated with N-380."
FT                   /evidence="ECO:0000269|PubMed:25918845"
FT   MUTAGEN         380
FT                   /note="D->N: Normal synapse localization, locomotion and,
FT                   endogenous and evoked excitatory postsynaptic currents;
FT                   when associated with S-378."
FT                   /evidence="ECO:0000269|PubMed:25918845"
FT   MUTAGEN         722
FT                   /note="D->A: Probable loss of catalytic activity. Reduced
FT                   locomotion and severe reduction in endogenous and evoked
FT                   excitatory postsynaptic currents."
FT                   /evidence="ECO:0000269|PubMed:25918845"
SQ   SEQUENCE   1119 AA;  124209 MW;  37004D0B646EF394 CRC64;
     MSVRGIRIWR RNDARFQPSI LVEKNGLDGS LLFQGGAIAT LDSDSTDVER RSYQKIVDAY
     GILGVLAITK DEAVLVAVTG VLSVGQLYGA DILKITNVEF ISLRTFGSVE NVDSRIIDLQ
     RLLSSQMFYF SSLQSYDLTR SAQHRDSHDC SDARFFWNRS LHFSFQRYGI DTDNWLLKCM
     AGSVLVRVVY VGANTGRVAL ISRLSCERVG TRFNVRGANY LGNVANFVET EQLLLFDEKE
     CSLLQIRGSI PLFWEQPGVN VGSHKVKLRA FETSLPAYHR HLSQLQHRYG EFAIVNLLGR
     KEGERVLGDA FKTQHKSSHF APLVDFIDFD YHAQMKISKE AIVQLKKKMS PHMTKHGFFY
     SMGKEIVKRQ TGVIRTNCLD CLDRTNAVQT AIGLQMSHDQ VAFLNLNAGK VNVEQRVEEI
     LRDLWQKNGD QCSTIYAGTG ALDGKSKLKD ASRSLARTIQ NNLMDGAKQE SFDLFLTGAA
     YDPRLFDRAC NILPPSLIQE SYYYHEYADA VSQLVERSPE IAEPQSIKIF VGTWNVNGGK
     NIHNVAFRNE SSLSHWIFAN SMTRLVSVED EQLADIVAIG VEELVDLNAS NMVKASTTNQ
     RMWCESIRKT LSEKAPFVLI GSEQLVGVCL FLFARPRVSP YLKDFAVASV KTGMGGATGN
     KGSVAFRIVV FSTSICFICS HFAAGQNEIR DRNEDFATTL KKIRFPLGRE IDSHDVIFWL
     GDFNYRINLS GDEVKNAVRN GDYAKLVEND QLTQQKALGQ TFVGFNEGQL TFAPTYKYDT
     FSDDYDTSEK CRAPAWTDRI LWKDQRKKGK TQLLSYDRSE LKTSDHRPVG AVFKVETFKV
     GGRKCVELIE DVVESMGPPD GTIIVSIAGK PRFPPQMFPP IHEKLKELGA QVQLSKFDDG
     DLWIVLNSGE MALAALSMDG LKIGGTDQIN VKLKSPDWAY ALKPHLSDFD LESFEVTAEE
     EALLGGTDGA VFEFADEDED AISVSSLTLT GSAPDRPRPP SARSEAISVA KLEWPTEQPN
     VLSTSMPTRA SSASLANSSW YEHVPPLAPP QSNNNKSPPQ ACLFNPFTQS APSPAPPPST
     IPLPPTRGAS VGPGPPAVPV RKAPPPPPRP VIPPRPKNM
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024